Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-25 @ 5:01 PM
NCT ID:
NCT04711603
Group ID:
EG003
Title:
Entire Study: P-MR Group
Description:
\[Double-blind period (6 weeks)\] The subjects in this group received the investigational drug for 6 weeks as the Placebo group.
\[Extension period (52 weeks)\]
The study drug was injected into the venous line of the dialysis circuit at the end of each dialysis session for 52 weeks (3 times weekly, 156 times in total).
The dose of the study drug was determined according to mentioned below, and the dose of the study drug from Week 6 to immediately before Week 34 will be determined based on the subject's dry weight before dialysis at Week 6. The dose of the study drug after Week 34 will be determined based on the subject's dry weight before dialysis at Week 34. The study drug (MR13A9) will not be administered at Week 58.
1. \<45.0 kg: 17.5 μg
2. \>=45.0 kg, \<65.0 kg: 25.0 μg
3. \>=65.0 kg, \<85.0 kg: 35.0 μg
4. \>=85.0 kg: 42.5 μg
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
38
Serious Number At Risk:
83
Other Number Affected:
74
Other Number At Risk:
83
Study:
NCT04711603
Results Section:
NCT04711603
Adverse Events Module:
NCT04711603